May 23
IN THIS ISSUE / MAY 23, 2018
- FDA declines to approve potential frown line treatment
- AAD Annual Meetings: Vital to resident education and the future of dermatology
- Dermatologist wins Republican nomination in Pennsylvania congressional primary race
- VA gives physicians the green light to practice telemedicine across state lines
- FDA eyeballs artificial intelligence in medicine
- 2019 committee appointment application now open
FDA declines to approve potential frown line treatment
The U.S. Food and Drug Administration has declined to approve prabotulinumtoxinA (DWP-450) for the treatment of frown lines. PrabotulinumtoxinA is a 900 kilodalton purified botulinum toxin type A complex. The FDA attributed its decision to issues regarding the chemistry and manufacturing of the product. However, the manufacturer, Evolus Inc., stated that these issues are “manageable” and the company remains committed to bringing the product to market by spring 2019.
Botulinum toxins aside, the FDA has approved a number of dermal fillers in recent years. But these aren’t just any fillers. The latest fillers target moderate to severe wrinkles and/or folds in specific anatomic locations. Learn more in Dermatology World.
Related Links:
- A new spin: Examining the use behind platelet rich plasma for dermatologic procedures – Dermatology World (May 2018)
- Body contouring carves out its niche – Dermatology World (June 2016)
- The elixir of youth – Dermatology World (March 2016)
AAD Annual Meetings: Vital to resident education and the future of dermatology
The AAD Resident Education Grant helps make sure residents can attend meetings vital to their future. “Residents will learn more in five days at the AAD Meeting than they can get from months of seeing patients,” said Mark Lebwohl, MD, FAAD. Hear more from Dr. Lebwohl and other physicians about how the meeting is meaningful to the future of dermatology and how you can help:
Send a Resident to Annual Meeting
Dermatologist wins Republican nomination in Pennsylvania congressional primary race
John Joyce, MD, FAAD, a dermatologist from Altoona, Pennsylvania has won the Republican nomination in Pennsylvania’s 13th congressional district primary. Dr. Joyce was up against seven other candidates vying for the Republican nomination. He will face Democrat Brent M. Ottaway in the Nov. 6 general election. The American Academy of Dermatology Association’s political action committee, SkinPAC, supported Dr. Joyce in his primary bid.
Related Links:
VA gives physicians the green light to practice telemedicine across state lines
The U.S. Department of Veterans Affairs (VA) has issued a rule that will allow VA physicians, nurses, and other health care providers to deliver health care services through telemedicine to patients across state lines or outside of a VA facility. The rule only applies to physicians and providers who work as VA employees. Those who are contracted with the VA are excluded.
Read more about how the practice of teledermatology is evolving and making its way to the private sector in Dermatology World. Also, learn more about how you can implement telemedicine and innovative ways to improve access for your patients today and tomorrow at the AADA’s Practice Management Center ― which now offers a new interactive map with state-specific teledermatology regulations.
Related Links:
- Exploring alternate sources of dermatologic care – Dermatology World (May 2017)
- Telemedicine – Dermatology World special focus issues (April 2015)
- Video: How to get started with telemedicine – Dermatology World (April 2015)
FDA eyeballs artificial intelligence in medicine
At a recent conference in Washington, D.C., Food and Drug Administration Commissioner Scott Gottlieb, MD, indicated that the agency is planning to launch initiatives that would encourage the use of artificial intelligence (AI) in medicine and drug development. “AI holds enormous promise for the future of medicine,” said Dr. Gottlieb. “We’re actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies. We expect to see an increasing number of AI-based submissions in the coming years, starting with medical imaging devices, and we’re working with experts in the field.”
Should dermatologists fear machine learning, or are concerns over their impending obsolescence unwarranted? Read more in Dermatology World.
Related Links:
- Deep neural networks for skin cancer classifications – Dermatology World (April 2017)
- The future of dermatology practice settings – Dermatology World (September 2016)
- Breaking the glass? Digital pathology makes waves in dermatology – Dermatology World (April 2016)
2019 committee appointment application now open
Every year, hundreds of dermatologists serve the Academy through its organizational governance structure and through other service opportunities. The Appointment Selection Committee, chaired by George J. Hruza, MD, MBA, has begun accepting applications to fill 2019 open appointments. Applications must be submitted by June 30, 2018. Members who are selected to serve will be contacted in the winter. Letters of recommendation are highly suggested but are not required.
Learn more about the specific committees and task forces, committee member responsibilities, and other opportunities, in the CCTF Resources-Governance Handbook.
